Business and Liquidity (Details) (USD $)	1 Months Ended		3 Months Ended		9 Months Ended
	Sep. 30, 2013	Feb. 28, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 item	Sep. 30, 2012	Dec. 31, 2012	Dec. 31, 2011
Business and Liquidity
Period since the entity has begun commercialization outside the United States of its newest product, RenalGuard					5 years
Number of operating segments					1
Loss from operations			$ (1,270,000)	$ (1,095,000)	$ (3,625,000)	$ (3,230,000)
Cash used in operations					4,190,000	2,564,000
Cash and cash equivalents	1,404,000		1,404,000	723,000	1,404,000	723,000	258,000	2,585,000
Additional capital	$ 1,750,000	$ 4,040,000